Rare disease with no Dx test or treatment may have new therapeutic options. WES performed by Otogenetics for NIH/NIAMS team led by Dr Battacharyya identifies causative somatic bone mutations/reveals novel pathway critical to melorheostosis. @NatureComms https://t.co/sCyFvv6DE5
Rare disease with no Dx test or treatment may have new therapeutic options. WES performed by Otogenetics for NIH/NIAMS team led by Dr Battacharyya identifies causative somatic bone mutations/reveals novel pathway critical to melorheostosis. @NatureComms https://t.co/sCyFvv6DE5
Studying #genetics is taking over- even one of Bill Gates' favorite books is on the "latest and greatest #genome technologies" #NGS https://t.co/AaLL9uvLTr